Please provide your email address to receive an email when new articles are posted on . Routine use of a molecular point-of-care test-and-treat strategy for influenza improved detection and other ...

3EO becomes the first point-of-care molecular technology to be retail priced below $15 per test. 3EO adds a breakthrough business model enabling more physician practices to upgrade technology from ...

Recent advances in portable and automated molecular diagnostic systems will address the previously unmet need for decentralized, point-of-care nucleic acid testing. Rapid, accurate diagnostic systems ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

To help patients get tested and treated for the flu, healthcare providers should embrace point-of-care molecular testing — a faster, more accurate diagnostic method, Norman Moore, PhD, director of ...

LONDON, Dec. 14, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced it has received $14.2M in grants from the Bill & Melinda ...

San Diego-based medical diagnostic company Cue Health Inc. announced Tuesday that it has received a $481 million award from the U.S. Department of Defense, on behalf of the U.S. Department of Health ...

The Point-of-Care Molecular Diagnostics Market is experiencing robust expansion driven by rising demand for rapid, accurate, and decentralized diagnostic testing across hospitals, clinics, and home ...

The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...